Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Acta Medica Martiniana

The Journal of Comenius University in Bratislava

3 Issues per year

Open Access
Online
ISSN
1335-8421
See all formats and pricing
More options …

Complications of Transrectal Prostate Biopsy

P. Cech / J. Luptak
  • Department of Urology. Come ni us University. Jcsscnius Medical Faculty (JFM CU) and University Hospital (UHM). Martin. Slovak Republic
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2014-05-30 | DOI: https://doi.org/10.2478/acm-2014-0004

Abstract

Objective: The aim of our study is to evaluate complications In patients who underwent a Transrectal Ultrasound Guided Prostate Biopsy (TRUS BP) at the Department of Urology of JFM CU and UHM in 2007-2008 and at the Department of Urology in Bojnice Hospital in 2009-2012.

Methodology, disclosures: In our study, patients with positive digital rectal examination (DRE) and/or with hig- her prostate specific antigen (PSA) levels (>4 ng/ml) are included. We excluded patients with PSA levels greater than 50ng/ml. as well as patients with less than 8 biopsy cores. The number of examined patients fulfilling the criteria was 474. An average age of them was 66.3 years (SD±8.3years). As an antibacterial prophylaxis, the patients were given fluoroquinolons in a dose of 500mg twice a day during a 3-day course of antibiotics, while the first dose was given one day before the procedure. In high risk patients, we used a single intramuscular dose of gentamycin 160mg right before the procedure followed by fluoroquinolons for the next five days.

Results: The most severe complication was vasovagal reaction, which occurred in 9 (1.9%) cases. Haematuria occurred in 122 (25.7%) cases up to 3 days and in 10 (2.1%) patients up to 7 days. Six patients (1.3%) required hospital admission for severe haematuria. Dysuria occurred in 71 patients (15%). Rectal bleeding occurred in 90 (19%) cases with an average 2 days of bleeding, from which 7 patients were admitted to hospital and administered haemostyptics. From the mentioned count. 2 (0.4%) patients underwent a rectal tamponade and one (0.2%) patient with arterial bleeding underwent an arterial ligation of a stricken artery. Haemospermia occurred in 71 (15%) cases. 23 (4.9%) patients suffered fever above 38°C. within whom in 7 (1.5%) cases was microscopicaly proven uri- nary tract infection requiring hospitalisation lasting 7 days on average. Sepsis occurred in 3 (0.6%) patients, symp- tomatic bacterial prostatitis in 6 (1.2%) cases and urinary retention occurred in one (0.2%) patient. There was not arty significant higher amount of complications in between 8-core and 10-core biopsy (P=0.26), not even in betwe- en 8-core and 12-core biopsy (P=0.32).

Conclusion: TRUS PB is a sale procedure with quite a low risk of complications. An important moment is a close monitoring right after the procedure. The most of the complications may persist for around two weeks and are trea- ted conservatively without persistent effects. Prophylaxis with broad spectrum antibiotics may provide an adequa- te coverage and lowers the risk of infectious complications.

Keywords: prostate biopsy; prostate cancer; complications; transrectal ultrasound

References

  • 1. Klečka J, Holubec L, Pešta M, Hora M, Topolčan O, Eret V. Nádorové markery karcinómu prostaty. Ces Urol 2008; 12(3): 173-185.Google Scholar

  • 2. Sigebara K, Miyagi T, Nakashima T, Shimamura M. Acute bacterial prostatitis after transrectal nedele biopsy: clinical analysis. J Clin Chemother 2008; 14: 40-43.Google Scholar

  • 3. Webb NR, Woo HH. Antibiotic prophylaxis for prostate biopsy. BJU International 2002; 89: 824-828.PubMedCrossrefGoogle Scholar

  • 4. EAU Guidelines 2013; Prostate cancer; 6. p: 18.Google Scholar

  • 5. Ecke TH, Gunia S, Bartel P, Hallmann S, Koch S, Ruttloff J. Complications and risk factors of transrectal ultrasound guided nedele biopsies of the prostate evaluated by questionnaire. Urol Oncol 2008; 26: 474-478.CrossrefWeb of ScienceGoogle Scholar

  • 6. Sieber P, Rommel F, Theodoran C. Contemporary prostate biopsy complication rates in community-based urology practice. Urology 2007; 70(3): 498-500.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 7. Ghani K, Dundas D, Patel U. Bleeding after transrectal ultrasonography-guided prostate biopsy: a study of 7- day morbidity after a six, eight and 12-core biopsy protocol. BJU Int 2004; 94(7): 1014-1020.PubMedGoogle Scholar

  • 8. Raaijmakers R, Kirkels WJ, Roobol MJ. Complication rates and risc factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 2002; 60: 826-830.Google Scholar

  • 9. Javorka K jr., Švihra J, Ľupták J, Eliáš B, Kliment J. Hodnotenie kvality života po transrektálnej biopsii prostaty pod ultrazvukovou kontrolou a jej komplikácie. Klinická onkologie 2000; 139: 758-761.Google Scholar

  • 10. Peyromaure M, Ravery V, Messas A, Toublanc M, Boccon-Gibod L. Pain and morbidity of an extensive prostate 10-biopsy protocol: a prospective study in 289 patients. J Urol. 2002; 167(1): 218-221.Google Scholar

  • 11. Collins GN, Lloyd SN, Hehir M, McKelvie GB. Multiple transrectal ultrasound-guided prostatic biopsies-true morbidity and patient acceptance. BJ Urol 1993; 71: 460-463.PubMedGoogle Scholar

  • 12. Kirkels WJ, Rietbergen JBW, Boeken Kruger AE, Kranse R, Schroder FH. Complication rates and risk factors of ultrasound-guided transrectal core biopsies of the prostate in a population based screening program. J Urol 1997; 146: 75-77.Google Scholar

  • 13. Kreutzer N, Wolter S, Haupt G, Engelmann U. Schmerzwahrnehmung und Komplikationen bei der transrektalen Prostatabiopsie. Aktuel Urol 2012; 33: 277-282.Google Scholar

  • 14. Zisman, A., Leibovici, D., Siegel, Y.I., Lindner, A. Complications and Quality of Life Impairment After Ultrasound Guided Prostate Biopsy - A Prospective Study 1999 Selected Abstracts from American Urological Association annual meeting.Google Scholar

  • 15. Pushkar’ Dlu., Govorov A.V. Complications of transrectal biopsy of the prostate. Urology 2005; 112(2): 40-42.Google Scholar

  • 16. Paul R, Scholer S, van Randenborgh H. Morbidity of prostatic biopsy for different biopsy strategies: is there a relation to core number and sampling region? Eur Urology 2004; 45: 450-456.CrossrefGoogle Scholar

  • 17. Naughton CK. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: Impact on cancer detection. J Urol 2000; 163: 168-171.Google Scholar

  • 18. Lugg J, Lettieri J, Stass H, Agarwal V. Determination of the concentration of ciprofloxacin in prostate tissue following administration of a single, 1000 mg, extended-release dose. J Chemother 2008; 20: 213-218.Google Scholar

  • 19. Lindstedt S, Lindstrom U, Ljunggren E, Wullt B, Grabe M. Single-dose antibiotic prophylaxis in core prostate biopsy: Impact of timing and identification of risk factors. Eur Urol 2006; 50: 832-837.PubMedCrossrefGoogle Scholar

  • 20. Tobias-Machado M, Correa TD, De Baros EL, Wroclawski ER. Antibiotic prophylaxis in prostate biopsy. A comperative randomized clinical assay between ciprofloxacin, norfloxacin and chloramphenicol. Int Braz J Urol 2003; 29(4): 313-319.Google Scholar

  • 21. Aron M, Rajeen TP, Gupta NP. Antibiotic prophylaxis for transrectal nedele biopsy of the prostate: a randomized controlled study. BJU Int 2000; 85: 492-494.Google Scholar

  • 22. Larsson P, Norming U, Tornblom M, Gustafsson O. Antibiotic prophylaxis for prostate biopsy: benefits and costs. Prostate Cancer Prostatic Dis. 1999; 2: 88-90.Google Scholar

  • 23. Schaeffer AJ, Montorsi F, Scattoni V, Perroncel R, Song J, Haverstock DC, Pertel PE. Comparison of a 3-day with a 1-day regimen of an extended-release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal nedele biopsy of the prostate. BJU Int 2007; 100: 51-57.Web of ScienceGoogle Scholar

About the article

Received: 2014-04-07

Accepted: 2014-04-30

Published Online: 2014-05-30

Published in Print: 2014-05-01


Citation Information: Acta Medica Martiniana, Volume 14, Issue 1, Pages 27–32, ISSN (Online) 1335-8421, DOI: https://doi.org/10.2478/acm-2014-0004.

Export Citation

© by P. Cech. This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. BY-NC-ND 3.0

Comments (0)

Please log in or register to comment.
Log in